ABN AMRO INVESTMENT SOLUTIONS

Position in ONC — BeOne Medicines Ltd.

CIK 2080520 PARIS CEDEX 008, I0

Position in ONC

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$18,672,374

+$4,547,293 QoQ

Shares Held

65,524

+37.8% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#40

of 282 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ABN AMRO INVESTMENT SOLUTIONS holds $84,184,851 across 9 Biotechnology names. ONC ranks #2 (22.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	84,631	$42,038,756
2	ONC	BeOne Medicines Ltd. This page	65,524	$18,672,374
3	ARGX	Argenx SE	9,902	$9,186,778
4	REGN	Regeneron Pharmaceuticals, Inc.	6,114	$3,812,323
5	RPRX	Royalty Pharma plc	63,500	$3,560,444
6	ALNY	Alnylam Pharmaceuticals, Inc.	7,557	$2,274,883
7	RVMD	Revolution Medicines, Inc.	11,990	$2,245,487
8	INSM	INSMED Inc	12,028	$1,282,425

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,672,374	65,524	+37.8%	Shares	Other	2026-07-23
2026-03-31	$14,125,081	47,564	+48.3%	Shares	Other	2026-05-12
2025-12-31	$9,745,008	32,076	+111.1%	Shares	Other	2026-02-06
2025-09-30	$5,177,617	15,197	-39.0%	Shares	Other	2025-11-07
2025-06-30	$6,031,174	24,915	-6.2%	Shares	Defined	2025-08-08
2025-03-31	$7,228,835	26,560	+8.8%	Shares	Defined	2025-08-27
2024-12-31	$4,508,401	24,408	-6.5%	Shares	Defined	2025-09-04
2024-09-30	$5,860,609	26,104	-8.2%	Shares	Defined	2025-09-04
2024-06-30	$4,057,392	28,439	0.0%	Shares	Defined	2025-09-04
2024-03-31	$4,447,575	28,439	+11.4%	Shares	Defined	2025-09-05
2023-12-31	$4,602,606	25,519	+1.0%	Shares	Defined	2025-09-05
2023-09-30	$4,546,753	25,278	+12.3%	Shares	Defined	2025-11-07
2023-06-30	$4,014,781	22,517	+5.7%	Shares	Defined	2025-09-05
2023-03-31	$4,590,789	21,300	—	Shares	Defined	2025-09-05
No filing history on record for this holder in this stock.